The number of people receiving treatment for advanced kidney failure - such as dialysis or kidney transplant - will double to over five million by 2030, mostly in developing regions such as Asia and Africa, a study said on Saturday.
Renal replacement therapy (RRT), through either dialysis or renal transplantation, is a life-saving yet high-cost treatment for people with end-stage kidney disease.
According to the latest research by the George Institute for Global Health published in The Lancet, the number of people receiving RRT is projected to grow from 2.618 million in 2010 to 5.439 million by 2030.
"However, the number of people without access to RRT will remain substantial," the study titled 'Worldwide access to treatment for end-stage kidney disease: a systematic review' said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app